Regulating forensic genetic genealogy
By Natalie Ram, Erin E. Murphy, and Sonia M. Suter,
Science
| 09. 24. 2021
In May 2021, Maryland enacted the first law in the United States—and in the world—that comprehensively regulates law enforcement’s use of consumer genetic data to investigate crimes (1). Until now, the primary restraint on law enforcement has come from consumer genetics platforms themselves, with some declining to cooperate, some covertly cooperating, and a handful working openly with criminal investigators. Courts have largely taken a hands-off approach, and one of the only efforts at oversight emerged from the US Department of Justice (DOJ), which issued an “interim” policy in November 2019. By contrast, Maryland’s new law—adopted with near-unanimous, bipartisan support—engaged a broad array of stakeholders and was adopted by elected officials after a transparent and open legislative process. Its success provides a roadmap for regulating genetic genealogy in a way that balances privacy and public safety, and its terms include six critical features that others should model moving forward.
Solving Crimes, Provoking Alarm
The technology at issue in the Maryland law came to the public’s attention with the high-profile arrest of Joseph James DeAngelo Jr. as the Golden State...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...